Table 3 Characteristics of the respiratory support delivered
From: Severe and critical COVID-19 in a tertiary center in Colombia, a retrospective cross-sectional study
Variable | n = 158 (%) | Patients discharged alive n = 101(%) | In-hospital death n = 57(%) | p | Patients not needing invasive mechanical ventilation. n = 95(%) | Patients requiring invasive mechanical ventilation, n = 63(%) | p |
|---|---|---|---|---|---|---|---|
High flow nasal oxygen and/or noninvasive ventilation | 57 (36) | (37.6) | 19 (33.3) | 0.59 | 32 (33.7) | 25 (39.7) | 0.4 |
Noninvasive ventilation | 24/57 (42) | 13/38 (34) | 11/19 (57.9) | 0.08 | 11 (34) | 13 (52) | 0.18 |
High flow nasal oxygen | 43/57 (75) | 30/38 (78.9) | 13/19 (68) | 0.51 | 26 (81) | 17 (68) | 0.24 |
Invasive mechanical ventilation | 63 (39.9) | 15 (14.9) | 48 (84.2) | 0.001 | |||
Days in Invasive Ventilatory Support, median (IQR) | 9 (3–15) | 10 (6–16) | 7 (3–14.7) | 0.6 |